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Abstract 
Introduction/Purpose: In vivo detection of cerebral microbleeds (CMBs) from T2* gradient recalled 
echo (GRE) magnitude image suffers from low specificity, modest inter-rater reproducibility and is 
biased by its sensitivity to acquisition parameters. New methods were proposed for improving this 
identification, but they mostly rely on 3D acquisitions, not always feasible in clinical practice. A fast 
2D phase processing technique for computing internal field maps (IFM) has been shown to make it 
possible to characterize CMBs through their magnetic signature in routine clinical setting, based on 
2D multi-slice acquisitions. However, its clinical interest for CMBs identification with respect to more 
common images remained to be assessed. To do so, systematic experiments were undertaken to 
compare the ratings obtained by trained observers with several image types, T2* magnitude, 
Susceptibility Weighted Imaging reconstructions (SWI) and IFM built from the same T2*-weighted 
acquisition.  
Materials/Methods: 15 participants from the MEMENTO multi-center cohort were selected: six 
subjects with numerous CMBs (20+/-6 CMBs), five subjects with a few CMBs (2 +/-1 CMBs) and 
four subjects without CMB. 2D multi-slice T2* GRE sequences were acquired on Philips and Siemens 
3T systems. After pilot experiments, T2* magnitude, Susceptibility Weighted Imaging (SWI) 
minimum intensity projection (mIP) on three slices and IFM were considered for the rating 
experiments. A graphical user interface (GUI) was designed in order to consistently display images in 
random order. Six raters of various background and expertise independently selected “definite” or 
“possible” CMBs. Rating results were compared with respect to a specific consensus reference, on 
both lesion and subject type points of view.  
Results: IFM yielded increased sensitivity and decreased false positives rate (FPR) for CMBs 
identification compared to T2* magnitude and SWI-mIP images. Inter-rater variability was decreased 
with IFM when identifying subjects with numerous lesions, with only a limited increase in rating time. 
IFM thus appears as an interesting candidate to improve CMBs identification in clinical setting.  
Keywords: Microbleeds, Magnetic susceptibility, Phase MRI, SWI  
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Introduction 
Cerebral microbleeds (CMBs), described as small foci of chronic blood products within brain 
parenchyma (Greenberg et al. 2009), were first seen in patients with small vessel diseases on specific 
MRI sequences that are sensitive to magnetic susceptibility. Correlation of these radiological findings 
with histopathological studies has generated considerable interest (Cordonnier 2011). CMBs are now 
commonly reported in the general population as well as in patients with specific disorders (Conijn et 
al. 2011). CMBs’ prevalence is highly variable among reports: from 47% to 80% in patients with 
intra-cerebral hemorrhage (Lee et al. 2004; Naka et al. 2004), from 8% to 71% in patients with 
ischemic stroke (Naka et al. 2004; Tsushima, Aoki, and Endo 2003), from 17% to 46% in patients 
with cognitive decline and dementia (C. Cordonnier et al. 2006; Hilal et al. 2014) and about 20% in 
healthy elderly population (Cordonnier 2011). Deep brain CMBs are associated with hypertensive 
arteriopathy (HTA), while those close to the cortex are associated with cerebral amyloid angiopathy 
(CAA), although they may also be present in patients with isolated cerebral small vessel disease (Park 
et al. 2013).  
CMBs identification using MRI remains complicated (Cordonnier 2011; Greenberg et al. 2009). As 
made of hemosiderin, they can be described as strongly super paramagnetic iron–storage complexes 
(Cordonnier 2011), whereas the surrounding brain parenchyma is diamagnetic. Thus, this magnetic 
susceptibility difference with surrounding brain parenchyma makes CMBs appear as magnetic 
inclusions, causing a local magnetic field inhomogeneity similar to the one that would be created by a 
unit dipole. At the voxel level, this inhomogeneity leads to intra-voxel phase dispersion and strong 
T2*-contrast. CMBs’ detection is thus commonly based on Gradient Recalled Echo (GRE) T2*-
weighted magnitude images, in which they appear as areas of signal loss. However, their appearance 
on these sequences is sensitive to imaging parameters such as echo time (TE) and B 0 field strength. 
Furthermore, blood vessels and cerebral micro-calcifications (CMCs) also have strong T2* effects and 
can be misidentified as CMBs. Physiologic calcifications commonly found in specific areas (e.g. 
pineal gland, choroid plexus, basal ganglia) can easily be identified but smaller calcifications at 
unexpected localization sometimes require a CT scan (Yamada et al. 1996). 
Specific GRE-based solutions have been proposed to address these issues or related ones, including 
different acquisition protocols and/or different signal processing methods such as Susceptibility 
weighted imaging (SWI) (Cheng et al. 2013; Goos et al. 2011; Nandigam et al. 2009; Vernooij et al. 
2008), Enhanced Susceptibility weighted angiography (ESWAN) (Guo et al. 2013), Quantitative 
susceptibility mapping (QSM) (Klohs et al. 2011; Liu et al. 2012; McAuley et al. 2010), internal field 
maps (IFM) (Guo et al. 2013; Kaaouana et al. 2015). SWI has already been considered for the 
diagnosis of CMBs. It is based on combining phase and magnitude images from 3D high resolution 
GRE acquisitions and aims at increasing detection sensitivity for paramagnetic structures such as veins 
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or hemorrhages (Goos et al. 2011; E. M Haacke et al. 2009; E. Mark Haacke and Reichenbach 2011; 
Nandigam et al. 2009; Reichenbach et al. 1997). A comparison between SWI and GRE T2* reported 
that conventional GRE T2* magnitude missed 67% of CMBs compared to SWI (Nandigam et al. 
2009; Cheng et al. 2013; Vernooij et al. 2008). The QSM reconstruction technique, aiming at 
quantifying susceptibility, should make it possible to estimate the real lesion load. A validation study 
on 3D multi-echo GRE T2* acquisitions on ten patients suspected of having experienced a stroke 
reported that the total susceptibility (TS) of CMBs was more consistent than CMBs size measurement 
(Liu et al. 2012). Nevertheless, SWI, ESWAN and QSM techniques have been designed and evaluated 
with 3D multi-echo GRE T2* acquisitions which may not be available in large cohorts. Internal field 
maps (IFM) can be computed with standard parameters from phase images of routine 2D T2* GRE 
single echo acquisitions. A method based on 2D harmonic filtering (2DHF) (Kaaouana et al. 2015) has 
been shown to allow generating appropriate internal field maps for discriminating CMBs and 
visualizing the dipole field patterns created by CMBs; this magnetic signature could be used in CMBs’ 
characterization. 
Overall, CMBs’ detection has limited reproducibility and is observer dependent (de Bresser et al. 
2013; Charidimou, Shakeshaft, and Werring 2012). This can be explained by confounding structures 
and artifacts as well differences in acquisition settings between studies. Previous studies comparing 
rating performance for advanced images vs standard magnitude images did in fact combine the 
advantages of 3D acquisitions with those of the new pre-processing techniques. Here, we aimed at 
evaluating the specific advantages of advanced image processing technique for CMB’s identification 
by trained raters. In fact, 3D GRE T2*-weighted acquisitions may not always be feasible in clinical 
setting and 2D acquisitions make it possible to ensure uniformity in multi-center clinical studies while 
guaranteeing reasonable acquisition time. Thus, routine 2D multi-slice GRE acquisitions were used as 
inputs in this study from which several types of reconstructions were derived: magnitude images, 
SWI-like images, and preprocessed phase images (IFM).  
The paper is organized as follows. In the first part, the dataset used for this comparison study is 
presented, followed by a description of the advanced pre-processing techniques and comparison 
experiments. Results are then detailed in the second part, regarding the reliability of the reference built 
specifically for this study and the performance of the method on both “single lesion” and “subject” 
points of view. 
Material and Methods  
Evaluation dataset 
The evaluation dataset was extracted from data acquired for the ongoing French national cohort named 
MEMENTO (Chene et al. 2014). MRI and PET acquisitions, provided by a network of 24 centers with 
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MRI systems from different manufacturers, models and field strengths, are monitored by the CATI, 
the French National Platform for Multi-center Neuroimaging Studies (http://www.cati-
neuroimaging.com/). A sub-sample of the first 382 MEMENTO participants were evaluated for 
CMBs (Kaaouana et al. 2015), and 77 subjects with CMBs were identified. This prevalence of 20% 
for this population (mean age was 55) was consistent with the prevalence reported for elderly subjects 
(Cordonnier 2011). For the current evaluation study, 15 subjects were selected in order to analyze six 
subjects with numerous CMBs [13-30 CMB], five subjects with few CMBs [1-4 CMB] and four 
subjects without CMB. MRI data for these 15 subjects were acquired on either Siemens (four centers, 
Verio systems, seven subjects) or Philips (three centers, Achieva systems, eight subjects) 3T systems. 
The acquisition protocol was described in (Kaaouana et al. 2015). 
Methods  
CMBs are made of hemosiderin and are detected on GRE images because of the local magnetic 
susceptibility variation they yield. Besides, GRE phase images are proportional to magnetic field 
variations and thus sensitive to local susceptibility variations. Both magnitude and phase images will 
thus be considered in this study.  
However, phase image analysis for local field variations is not straightforward. In fact, phase wraps 
appear on the images because phase is defined in the [ - π , π ] interval and local variations are hidden 
in large scale field variations resulting from background effects, dominated by the magnetic 
susceptibility sharp edge of air-tissue interfaces.  
The extraction of relevant internal field information thus requires two preliminary steps: phase 
unwrapping and background field removal (E. Mark Haacke and Reichenbach 2011). These two pre-
processing steps are embedded in the two methods chosen for this study, SWI and IFM, as described 
below.  
Susceptibility Weighted Imaging (SWI) 
SWI relies on combining phase and magnitude images (E. Mark Haacke and Reichenbach 2011), 
phase information being used to enhance blood-related contrast on magnitude image (e.g. veins). 
Phase images are first high-pass filtered (HPF) to extract local information and then transformed in a 
phase mask with values in the       interval. In this study, the HPF phase image was obtained through 
the following steps. The complex-valued image was first generated from magnitude and phase images. 
It was then low-pass filtered slice by slice with a two dimensional Gaussian filter in Fourier domain. 
The HPF phase image was then estimated as the phase component of the ratio between complex-
valued and low-pass-filtered images. The HPF phase image was then transformed in a consistent phase 
mask which was then applied N times on the original magnitude image to highlight voxels with a high 
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phase value. The standard-deviation of the Gaussian filter, σ, and the N parameter were empirically 
chosen in order to optimize the setting for CMBs detection on 2D data. The σ parameter was set to 36 
pixels, as recommended in (E. Mark Haacke and Reichenbach 2011), and N was set to 8. 
Internal Field Map (IFM)  
A 2D-based method for phase unwrapping and harmonic filtering, based on solving Poisson equation 
(Song et al. 1995), has been proposed as an efficient mean for obtaining the IFM (Kaaouana et al. 
2015) on 2D acquisitions. This method was shown to solve the potential slice-to-slice phase 
inconsistency that may occur in 2D multi-slice T2* GRE datasets. The magnetic field observed inside 
the brain, B , can be decomposed as the sum of the magnetic field due to internal sources, Bin , and the 
one induced by external sources, Bout . From Maxwell’s equations, B out is harmonic inside the brain 
(ΔBout=0), resulting in ΔB=ΔBin ( Δ denotes the Laplacian). Consequently, field variations due to 
external sources can be filtered out through a second order derivative, followed by a second order 
integration using adequate boundary conditions. In the process, the Laplacian of the field Bin , which 
locally depends on susceptibility distribution, is set to 0 outside the brain to remove external 
susceptibility effects. Paramagnetic dot-like inclusions such as CMBs appear as a dipolar field on the 
resulting IFM (see Figure 1 and (Kaaouana et al. 2015)). CMBs can be better discriminated by this 
magnetic signature. 
Figure 1 here 
Figure 1: Magnitude image (a) raw phase image (b), IFM (c), SWI (d), SWI-mIP, minimum intensity 
projection on three consecutive slices (e) are displayed.  
Evaluation experiments  
In order to determine the influence of the type of image for CMBs’ identification, rating was 
performed by several raters in different conditions. A pilot experiment was first carried-out in order to 
determine the optimal settings for the rating experiments (see appendix 1 for more details). Three 
types of images were finally considered as good candidates for CMBs rating in clinical setting: T2* 
magnitude image, SWI-mIP image (mIP being done on three slices with a resulting slab thickness of 
7.5 mm) and IFM image. 
Experiment 
Rating was performed independently by six raters (one session each) with various levels of expertise: 
a trained clinical research assistant, a trained engineer, two junior neuroradiologists and two senior 
neuroradiologists. For each rater, all scans were scored in a single session. All observers were blind to 
image type, clinical information and other ratings. In order to facilitate detection, interactive 
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visualization tuning was embedded in a specific Graphical User Interface (GUI) built with GUIDE in 
MATLAB (see Figure 6 appendix 1). As in MARS (S. M. Gregoire et al. 2009) and BOMBS 
(Charlotte Cordonnier et al. 2009) rating scales, a certainty score was included and CMBs could be 
categorized as “definite” or “possible”. The aim of this categorization was both to facilitate the rating 
in case of uncertainty and to differentiate the amount of variability that came from clear and dubious 
CMBs. CMBs were defined as small round areas of signal loss on axial slices without 3D connectivity 
that would characterize vessels on sequences that are sensitive to magnetic susceptibility. Their size 
may vary from 2 to 10 mm (Greenberg et al. 2009). 
Building-up of the reference 
After the series of ratings was completed, a reference was built by two trained neuroradiologists, one 
of whom did not participate to the comparison experiments. All the CMBs that were detected by any 
rater on any image during comparison experiments were reassessed independently by each trained 
neuroradiologist. Here, the three image types were displayed simultaneously through a specific GUI 
(reference GUI). The resulting two sets of 15 reference images were then combined to create a set of 
15 consensus images using a given explicit scoring rule (Table 1). Briefly, if a lesion was identified by 
both observers and at least one observer considers it as definite, then it was rated as “definite CMB” in 
the consensus. If it was identified by only one observer as “possible” then it was discarded from the 
reference. If it was identified by only one observer as “definite”, then it was considered as a “possible 
CMB”.  
  
Exp.1 
no p d 
Exp.2 
no no no p 
p no p d 
d p d d 
 
Table 1: Reference consensus building up, scoring rules: “no” for discarded lesion, “p” for “possible 
CMB” and “d” for “definite CMB”.  
 
Because of the well-known inter-rater variability when rating CMBs, the reliability of the consensus 
reference needed to be evaluated, to ensure that the consensus rating could be considered as a 
meaningful reference. Rating experiments were then analyzed on a lesion-based point of view by 
comparing the decision of each rater for each lesion in the reference. Two types of identification were 
analyzed: 1. all detected CMBs (either definite or possible); 2. CMBs detected as definite only. 
Furthermore, in order to assess clinical usefulness, ratings and reproducibility analyses were carried 
out on a subject-type point of view, by classifying patients in three groups: no CMB (G1), few CMBs 
(G2, less than 10 CMBs) and numerous CMBs (G3, more than 10 CMBs). Finally, rating durations 
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were also analyzed, in order to evaluate clinical feasibility of IFM-based rating with respect to more 
standard T2* magnitude and SWI-mIP. 
Results  
The specificity (defined as           ) cannot be determined since TN (true negatives) is not a 
meaningful measure in CMBs detection. Here, the performance of each rater is characterized through 
the false positives (FP) rate (FPR), false negatives (FN) and true positives (TP). Dice coefficients 
 
   
         
   which combines TP, FP and FN, were also calculated for each rater. 
Reference 
In order to evaluate the reliability of the consensus reference, detected CMBs were compared between 
expert raters. Results are given in Table 2, through the number of CMBs (all or definite CMBs) 
detected by each of the two expert raters, the number of CMBs detected by both raters (overlap) or by 
a single rater (discrepancy) and the number of CMBs on the consensus computed by the scoring rules 
described in Table 1.  
 
  expert.1 expert.2 Overlap / discrepancy consensus 
subject d all d all d/d d/p d/no d all 
2 0 2 0 0 0 0 0 0 0 
12 0 1 0 0 0 0 0 0 0 
13 0 1 0 0 0 0 0 0 0 
15 0 4 0 0 0 0 0 0 0 
6 0 0 1 1 0 0 1 0 1 
5 0 2 1 1 0 1 0 1 1 
10 2 5 2 2 2 0 0 2 2 
1 4 7 1 2 1 1 2 2 4 
8 3 6 4 4 3 1 0 4 4 
9 12 12 12 16 11 0 2 11 13 
11 15 15 15 15 14 0 2 14 16 
7 16 17 12 16 11 3 3 14 17 
3 17 18 15 17 9 1 13 10 23 
4 19 24 16 24 12 6 5 18 24 
14 30 30 12 36 12 18 0 30 30 
Total 118 144 91 134 75 31 28 106 135 
 
Table 2: Reference building-up: CMBs detected by expert raters and consensus result. “d” refers to 
“definite” CMBs and “all” to the sum of definite and possible CMBs. “d/d” is the number of CMBs 
detected as definite by both raters. “d/p” is the number of CMBs detected as definite by one rater and 
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possible by the other, “d/no” is the number of CMBs detected as “definite” by one observer while not 
detected by the other.  
 
Cohen’s kappa coefficient was computed to compare between raters the number of CMBs detected for 
each subject. When considering all lesions, the kappa value was 0.5 (p-value=0.01) and for definite 
lesions only, the kappa value was 0.54 (p-value=0.02).  
Overall, the agreement on CMBs detection was satisfactory. Apart from one subject (subject 3 with 13 
discrepant CMBs), the discrepancy between both raters was negligible (median for “no CMB”: 0, “few 
CMBs”: 0 and “numerous CMBs”: 2.5). Examples of between-raters discrepancies are illustrated in 
Figure 2. 
Figure 2 here 
Figure 2: between-raters discrepancies during reference building-up; First column: magnitude 
images, second column: SWI-mIP images, third column: internal field map. First two rows: 
discrepancy cases from subject 3. Lesions shown here by red and green arrows are doubtful due to 
their shape that can be seen either as two adjacent round CMBs or as a relatively linear structure like 
a blood vessel. The CMB showed by the yellow arrow is very close to susceptibility artifact. Last two 
rows: discrepancy cases from subject 14. CMBs pointed by orange and blue arrows may have been 
ambiguous because of low contrast.  
Rating results: lesion-based point of view 
Blind ratings were analyzed with respect to the consensus reference, in order to evaluate the 
performance of each image type independently for lesion detection. Because of the large variability in 
lesion number between subjects, TP, FP and FN were computed for each rater over all the CMBs 
detected on all subjects. Note that “all” refers to the union of “definite” and “possible” CMBs. The 
overall count of CMBs detected by each rater is given in Table 3 for the three image types (T2* 
magnitude, SWI-mIP and IFM). Total numbers of CMBs, TP, FN and FP are detailed for each rater.  
IFM yields a slight improvement of the overall ratings with respect to T2* whereas SWI-mIP yields 
systematic higher numbers of false positives. TP were lower for SWI than for T2* and IFM (78 vs 88-
89). Both FN and FP were higher for SWI (FN: 57 vs 48-46, FP: 34 vs 16-9). Furthermore, ranges for 
TP, FN and FP were narrower for IFM than T2* (TP: 32 vs 54, FN: 32 vs 54, FP: 73 vs 100). Dice 
coefficients, given for each rater in Table 3, were slightly higher for IFM than T2* and SWI-mIP (0.74 
vs 0.69-0.61). 
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  Total number ∑ TP ∑ FN ∑ FP Dice Coef 
  T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM 
CRA 63 70 82 51 42 73 84 93 62 12 28 9 0,52 0.41 0.67 
Exp.Junior1 82 81 89 74 65 86 61 70 49 8 16 3 0,68 0.60 0.77 
Exp.Senior1 132 113 107 99 78 95 36 57 40 33 35 12 0,74 0.63 0.79 
Trained. 
Ing 
100 115 101 83 82 92 52 53 43 17 33 9 0,71 0.66 0.78 
Exp.Senior2 107 119 84 92 78 78 43 57 57 15 41 6 0,76 0.61 0.71 
Exp.Junior2 213 268 181 105 99 105 30 36 30 108 169 76 0,6 0.49 0.66 
Median 104 114 95 88 78 89 48 57 46 16 34 9 0.69 0.61 0.74 
Min 63 70 82 51 42 73 30 36 30 8 16 3 0.52 0.41 0.66 
Max 213 268 181 105 99 105 84 93 62 108 169 76 0.76 0.66 0.97 
 
Table 3: Total number of detected CMBs and comparison with the reference: TP, FN, FP and Dice.  
 
When comparing performances between raters, we note that two raters tend to underestimate the 
number of CMBs (CRA and Exp.Junior1) and one tends to largely overestimate it (Exp.junior2). 
Interestingly, this difference is lessened by the use of IFM with respect to the other two image types 
(total count range: 99 for IFM vs 150 for T2* and 198 for SWI-mIP). 
In order to better understand the detection pattern between raters, ratings for definite CMBs were also 
analyzed. Detailed results are given in Table 4.  
  
Total number ∑ TP ∑ FN ∑ FP Dice Coef 
T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM 
CRA 56 54 66 47 38 62 59 68 44 9 16 4 0.58 0.48 0.72 
Exp.Junior1 72 73 81 67 60 78 39 46 28 5 13 3 0.75 0.67 0.83 
Exp.Senior1 87 74 88 81 66 84 25 40 22 6 8 4 0.84 0.73 0.87 
Trained. 
Ing 
76 87 91 67 65 85 39 41 21 9 22 6 0.74 0.67 0.86 
Exp.Senior2 91 108 74 77 69 70 29 37 36 14 39 4 0.78 0.64 0.78 
Exp.Junior2 111 162 102 86 84 85 20 22 21 25 78 17 0.79 0.63 0.82 
Median 82 81 85 72 66 81 34 41 25 9 19 4 0.77 0.66 0.83 
Min 56 54 66 47 38 62 20 22 21 5 8 3 0.58 0.48 0.72 
Max 111 162 102 86 84 85 59 68 44 25 78 17 0.84 0.73 0.87 
 
Table 4: Total number of CMBs identified as “definite” and comparison with the reference.  
 
Overall, the results are in accordance with Table 3. More specifically, IFM yields a higher number of 
definite CMBs than the other two image types (81 vs 72 and 66 for T2* and SWI-mIP, respectively) 
and smaller number of FN (25 vs 34 and 41) and FP (4 vs 9 and 19). Value ranges follow the same 
trend (TP: 23 vs 39 and 16, FN: 23 vs 39 and 46, FP: 14 vs 20 and 70). Dice values for definite CMBs 
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were also higher for IFM than T2* and SWI-mIP (0.83 vs 0.77-0.66). IFM thus seems to mitigate 
inter-rater variability for definite lesions (range for total number: 36 vs 55 and 108).  
Rating results: subject-type point of view 
In order to evaluate the three image types with respect to their clinical usefulness, rating results were 
evaluated for each subgroup (“no CMB”, “few CMBs”, “numerous CMBs”) (Table 5).  
 
∑ TP ∑ FN ∑ FP 
 
T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM 
G1 
(N=4) 
Median             2 2 0 
Min             0 0 0 
Max             10 5 4 
G2 
(N=5) 
Median 4 3 4 9 9 8 4 5 1 
Min 3 2 2 4 7 6 0 3 0 
Max 8 5 6 9 10 10 31 7 19 
G3 
(N=6) 
Median 82 76 85 41 48 38 13 27 7 
Min 48 38 70 22 27 23 5 12 2 
Max 101 96 100 75 85 53 67 160 53 
 
Table 5: Rating results for all detected CMBs for each subject group (see Table 8 in appendix 2 for 
more details).  
 
The overall trend is confirmed for the subgroups, FPR being decreased by IFM with respect to T2* 
and SWI-mIP ((0 vs 2 and 2 for G1), (1 vs 4 and 5 G2) and (7 vs 13 and 27 for G3)), even if the 
performance is more balanced between methods for “no CMB” and “few CMBs” groups.  
To investigate clinical relevance, image types were compared regarding to their ability to correctly 
classify the subjects in the three groups of interest. The number of correctly classified subjects for each 
rater and each image type is given in Table 6. 
 
G1 (N=4) G2 (N=5) G3 (N=6) Total 
T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM T2* 
SWI-
mIP 
IFM 
CRA 3 1 2 2 3 2 2 1 5 7 5 9 
Exp.Junior1 3 3 4 2 2 2 4 3 5 9 8 11 
Exp.Senior1 1 2 4 3 2 4 6 5 6 10 9 14 
Trained. 
Ing 
4 2 4 4 3 2 5 5 6 13 10 12 
Exp.Senior2 3 4 4 2 2 2 6 5 5 11 11 11 
Exp.Junior2 1 3 2 2 2 3 6 4 5 9 9 10 
Median 3 2,5 4 2 2 2 5 4,5 5 9,5 9 11 
Min 1 1 2 2 2 2 2 1 5 7 5 9 
Max 4 4 4 4 3 4 6 5 6 13 11 14 
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Table 6: Number of correctly classified patients using the three types of images.  
 
Overall T2* magnitude and IFM classify better than SWI-mIP (median value: G1: 3/4 and 4/4 vs 
2.5/4, G2: 2/5 and 2/5 vs 2/5, G3: 5.5/6 and 5/6 vs 4.5/6). IFM yields more similar results between 
raters than T2* magnitude and SWI-mIP (ranges: G1: 2 vs 3 and 3, G2: 2 vs 2 and 1, G3: 1 vs 4 and 
4). 
Table 7 indicates recorded rating duration. Ratings from IFM took longer in most cases, but the 
relative difference decreased from participants with no CMBs to participants with numerous CMBs. In 
the worst case, it took only 1.2 times longer. Interestingly, for all image types, it took less time to do 
the rating for participants with few CMBs than those with no CMB. 
 
 
T2* 
SWI-
mIP 
IFM mean 
G1 
(N=4) 
70 68 84 74 
G2 
(N=5) 
58 47 54 53 
G3 
(N=6) 
172 173 193 179 
mean 100 96 110 
 
 
Table 7: Mean recorded rating durations by image type and subject-type (in seconds).  
Discussion  
We presented here a comparison of CMBs detection performance when using three different kinds of 
images built from the same 2D GRE T2* weighted dataset: T2* magnitude, SWI-mIP and IFM. Blind 
ratings by six raters were evaluated with respect to a reference built from a reliable consensus between 
two expert raters. Overall, 2D-dedicated phase processing yielding IFM proved a very promising tool 
to improve CMB detection in clinical setting. In fact, it yielded increased sensitivity and decreased 
FPR compared to T2* magnitude and SWI-mIP images for lesion detection. Furthermore, IFM yielded 
less inter-rater variability when classifying patients with numerous lesions than both other methods, 
with only a slight increase in rating duration. 
One of the main novelties of our work was to compare between ratings performed on images obtained 
from the same 2D acquisition. Previous studies (Vernooij et al. 2008) compared 2D T2* magnitude 
images and 3D SWI; the differences that was obtained in this study may in fact be mainly due to the 
differences between 2D and 3D acquisitions. Using a unique acquisition was motivated by the fact that 
2D GRE multi-slice sequences are more common than 3D multi-echo GRE T2* in large multi-center 
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clinical research studies. IFM thus proved an efficient mean to improve CMBs detection. The method 
we used here, 2DHF, removes 2D acquisition and / or reconstruction artifacts from phase images 
while keeping fine details with limited border effects.  
False positives in CMB detection can be explained by CMBs mimics, which have similar shape and 
signal properties.  
The most frequent source of false positives is linked with blood vessels when not fully embedded in 
the acquired slice. In fact, when blood vessels are really perpendicular to acquisition plane, they will 
appear as round hyposignal. In some cases, SWI-mIP may help to differentiate these vascular-related 
mimics as the projection makes it possible to highlight the 3D tubular shape, as illustrated in Figure 3. 
Less frequent false positives originate from susceptibility artifacts and Partial Volume Effect (PVE). 
PVE-related mimics are more likely to occur adjacent to the petrous temporal bones, para-nasal 
sinuses, frontal bones, orbit and occipital bone (Werring 2011; S. M. F. Gregoire 2014; Greenberg et 
al. 2009). Experienced raters seem to better distinguish between PVE-related mimics and CMBs as 
they rely more on anatomical criteria.  
 Figure 3 here 
 
Figure 3: Example of FPs detected on T2*-magnitude image; these two hypointensities, pointed by 
blue arrows, were recognized as vascular-related mimics on SWI-mIP image because of their 
tubular shape.  
 
Although the use of SWI with 3D-acquisitions is known to increase the contrast of CMBs, allowing to 
detect smaller CMBs, here SWI yielded increased FPR on 2D acquisitions. In fact, SWI may enhance 
flow voids from small blood vessels and hyposignal artifact, thus creating new mimics. Thus, the 
increased sensitivity with SWI is balanced by a higher FPR. Moreover, the blooming effect is 
emphasized by SWI compared to magnitude images and could merge close CMBs. Finally, high pass 
filtering technique has been proven sub-optimal for background field removal, crucial for SWI 
(Kaaouana et al. 2015). This could yield an enhancement of some artifactual voxels and increased the 
FPR. 
Undetected CMBs are predominantly small lesions with low contrast with respect to their background. 
The criterion based on how much of the CMB is embedded in the parenchyma varies between authors 
and may lead to miss CMBs very close to sulci. Examples of undetected CMBs are illustrated in 
Figure 4.  
Figure 4a and 4b here 
 
(a)(b) 
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Figure 4: Example of undetected CMBs due to its low contrast (a) and/or its distance to sulci (b).  
 
The efficient calculation of IFM with the 2DHF method requires expressing boundary conditions to 
define the “internal” region of interest. These boundary conditions are derived from a mask of the 
region of interest, calculated using SPM (Statistical Parametric Mapping) software as described in 
(Kaaouana et al. 2015), and named the brain mask. However, the border of the brain mask co-localizes 
with areas of strong susceptibility gradients, thus leading to potentially strong border effects. To 
reduce these border effects, the brain mask was eroded. Theoretically, this may lead to miss little areas 
of the cortex, and thus cortical CMBs, as shown in the example in Figure 5. The use of both IFM and 
T2* magnitude images may help solve this issue for CMB detection.  
 Figure 5 here 
 
Figure 5: CMB on the outer cortical part not visible on IFM; T2*-magnitude image shows two 
lesions (a spread lesion in the occipital lobe and a CMB (red arrow)). The hemorrhage was still 
seen in the IFM while the CMB disappeared due to masking operation.  
 
QSM technique was not considered in this study. In fact, the dipole inversion underlying QSM is 
intrinsically three dimensional and thus strong anisotropic resolution may lead to large error 
propagation into resulting QSM maps. Moreover, regularization parameter setting is a challenging 
issue for multi-center data. QSM requires further investigation and validation and clinicians may need 
more training to interpret resulting maps. 
Similar to SWI, IFM enhances the contrast of paramagnetic structures (Figure 2), and thus increases 
sensitivity with respect to T2*-magnitude images. However, compared to SWI, IFM further yields a 
magnetic signature of CMBs. In fact, these inclusions behave like small magnetic dipoles and thus 
create magnetic field patterns similar to those of dipoles; this dipolar magnetic field appears as a ring-
like effect in the axial plane in IFM. The sign pattern depends on the lesion susceptibility class 
(paramagnetic or diamagnetic) and allows to discriminate between CMBs and cerebral micro-
calcifications related mimics (Kaaouana et al. 2015). Overall, IFM thus improve sensitivity (with 
respect to magnitude image) and decrease FPR (with respect to SWI-mIP). This results in a better 
characterization of subjects between “few CMBs” and “numerous CMBs”. 
Sensitivity and FPR of CMB detection appeared to vary between raters. Three types of rater behaviors 
were noted: two raters identified less CMBs on all image types and thus tended to under-rate (CRA 
and Exp.Junior1); one rater largely over-rated (Exp.Junior2); the last three raters had a similar 
tendency for medium rating (Trained.Ing and the two Exp.Seniors). For the two “under-raters”, IFM 
was more sensitive and more specific than T2* magnitude and SWI-mIP. By contrast, for the “over-
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rater”, sensitivity was very high for all image types, but most FPs were identified on SWI-mIP and 
FPR was twice better for IFM than T2* magnitude and SWI-mIP. For the most experienced raters, all 
image types were comparable regarding sensitivity but IFM shows lower FPR.  
IFM proved to yield only a slight increase in rating duration, even though it was a new image type for 
all raters. Rating duration may be reduced by making a better use of the magnetic signature in the 
visualization tool.  
Although studies on CMBs are becoming more common, some ambiguity remains on their rating 
leading in low inter-rater reproducibility. In fact, the main reasons of between-raters discrepancy are 
low contrast, distance with respect to sulci and lesion size. Better integrating new neuroimaging tools 
is likely to lead to considerable improvements with respect to these issues.  
For reference building-up, consensus was obtained with a specific scoring rule, in order to take into 
account the intrinsic variability of CMB detection (definite and possible CMBs). In fact, although the 
two observers reassessed the CMBs by considering all image types simultaneously, agreement was not 
perfect and a few cases of non-negligible disagreement were noticed. Even though relying on a third 
observer or consensus meetings may have been more standard approaches, both may suffer from 
subjective bias, whereas our approach considered both observer equally.  
Two visual scales have been proposed, MARS (The Microbleed Anatomical Rating Scale) (S. M. 
Gregoire et al. 2009) and BOMBS (Brain Observer Microbleed Scale) (Charlotte Cordonnier et al. 
2009). These scales were designed for clinical practice on T2* GRE weighted images and aimed at 
characterizing the number of CMBs and their distribution in the brain, as the clinical relevance of 
CMBs has been shown to be related with their localization. Here, a specific GUI was used to record 
the coordinates of each identified lesion allowing more accurate analysis of agreement or discrepancy 
cases. Moreover, rating results are embedded within an image with voxels labeled as “definite CMBs” 
and “possible CMBs” that can be combined either with a registered atlas or with a segmentation 
method to create an automatic report corresponding to the rating scales. 
In this study, we have shown that IFM appears as an interesting add-on to T2*-magnitude image for 
the detection of CMBs. As expected, it allows discriminating mimics from real CMBs, visible “ring 
like” effects making it more specific in deep white and grey matter. On the contrary, T2*-magnitude 
image only and SWI-mIP seemed to increase false positives detection. IFM offers a simple and 
practical solution to assess the presence, number and distribution of CMBs on standard clinical multi-
center dataset. Further clinical studies on more subjects would help better assess the advantages of 
each type of images with respect to clinical usefulness, together with histological studies in order to 
infer the physical meaning of the magnetic signature. Finally, a comparison on 3D isotropic datasets 
would allow a better assessment of advantages of IFM with respect to SWI when these datasets are 
available. 
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Appendix 
Appendix 1: Pilot experiment 
A pilot experiment was first carried-out in order to evaluate the experiment settings: number of 
subjects, image types and the specifically designed Graphical User Interface (GUI) built with GUIDE 
in MATLAB. This was conducted by an experienced neuroradiologist who selected the image types to 
be considered. Possible image types included: T2* magnitude, IFM and SWI minimum intensity 
projection (mIP) on n slices ( n=[ 2,3,4 ] ). 15 subjects proved feasible and T2* magnitude, SWI-mIP 
on three slices (slab thickness of 12mm) and IFM were kept for the comparison experiments and the 
GUI was finalized as in Figure 6. This evaluation GUI allows for displaying the overall 45 images, 
randomized on subjects and image types in order not to bias the comparison.  
Figure 6a and 6b here 
(a) (b) 
 
Figure 6: (a) Evaluation GUI when IFM (on the left) is displayed (Magnitude image is on the right) 
and (b) when SWI-mIP is displayed.  
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Appendix 2  
Table 8 presents the rating results for all detected CMBs for each subject group (details of Table 5). 
 
 
 
Table 8: Rating results for all detected CMBs for each subject group (details of Table 5).  
 
 
  
G1 (N=4) G2 (N=5) G3 (N=6) 
∑ FP ∑ TP ∑ FN ∑ FP ∑ TP ∑ FN ∑ FP 
T2* SWI-mIP  IFM   T2*   SWI-mIP   IFM   T2*   SWI-mIP   IFM   T2*   SWI-mIP   IFM   T2*   SWI-mIP   IFM   T2*   SWI-mIP   IFM   T2*   SWI-mIP   IFM  
CRA 2 5 3 3 4 3 9 8 9 5 7 1 48 38 70 75 85 53 5 16 5 
Exp.Junior1 1 1 0 4 3 3 8 9 9 1 3 0 70 62 83 53 61 40 6 12 3 
Exp.Senior1 3 2 0 3 3 6 9 9 6 2 6 1 96 75 89 27 48 34 28 27 11 
Trained. Ing 0 2 0 8 5 5 4 7 7 6 4 1 75 77 87 48 46 36 11 27 8 
Exp.Senior2 1 0 0 3 2 2 9 10 10 0 4 4 89 76 76 34 47 47 14 37 2 
Exp.Junior2 10 2 4 4 3 5 8 9 7 31 7 19 101 96 96 22 27 23 67 160 53 
Median 2 2 0 4 3 4 9 9 8 4 5 1 82 76 76 41 48 38 13 27 7 
Min  0 0 0 3 2 2 4 7 6 0 3 0 48 38 38 22 27 23 5 12 2 
Max 10 5 4 8 5 6 9 10 10 31 7 19 101 96 96 75 85 53 67 160 53 
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Figure 6b 
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Highlights 
• We introduce an evaluation of phase-contrast for CMBs detection in clinical setting. 
• Comparison included T2* magnitude, SWI-mIP and IFM images using a specific GUI. 
• Rating results showed an improved sensitivity of IFM compared to T2*and SWI-mIP. 
• A decreased false positive rate with IFM with respect to T2*and SWI-mIP was 
proved. 
• We demonstrate a decreased inter-rater variability with IFM. 
